Ac-Devd-AFC
To Order Contact us: bjorn@lembcke.dk
Ac-DEVD-AFC *CAS 201608-14-2* |
|||
13401 | AAT Bioquest | 5 mg | EUR 158.4 |
Z-DEVD-AFC |
|||
A8753-25 | ApexBio | 25 mg | EUR 547.2 |
Description: Z-DEVD-AFC is a fluorometric substrate for caspase-3 (Km = 9.7µM) and other related caspases. The sequence DEVD is based on PARP cleavage at Asp216 for caspase-3. |
Z-DEVD-AFC |
|||
A8753-5 | ApexBio | 5 mg | EUR 199.2 |
Description: Z-DEVD-AFC is a fluorometric substrate for caspase-3 (Km = 9.7µM) and other related caspases. The sequence DEVD is based on PARP cleavage at Asp216 for caspase-3. |
Z-DEVD-AFC |
|||
13420 | AAT Bioquest | 5 mg | EUR 211.2 |
Ac-DEVD-pNA |
|||
A8744-25 | ApexBio | 25 mg | EUR 338.4 |
Description: Ac-DEVD-pNA is a colorimetric substrate for caspase-3 (Km=9.7µM) and caspases-1, -4, -6, and -7 [1]. Ac is the acetyl group and pNA is p-nitroanilide. Sequence is based on PARP (poly(ADPribose) polymerase) cleavage site Asp216 for caspase-3 |
Ac-DEVD-pNA |
|||
A8744-5 | ApexBio | 5 mg | EUR 142.8 |
Description: Ac-DEVD-pNA is a colorimetric substrate for caspase-3 (Km=9.7µM) and caspases-1, -4, -6, and -7 [1]. Ac is the acetyl group and pNA is p-nitroanilide. Sequence is based on PARP (poly(ADPribose) polymerase) cleavage site Asp216 for caspase-3 |
Ac-DEVD-CMK |
|||
C5528-1 | ApexBio | 1 mg | EUR 166.8 |
Description: Ac-DEVD-CMK is a cell-permeable and irreversible caspase-3 inhibitor [1][2][3]. Apoptosis is a process of programmed cell death that occurs in multicellular organisms. |
Ac-DEVD-CMK |
|||
C5528-5 | ApexBio | 5 mg | EUR 548.4 |
Description: Ac-DEVD-CMK is a cell-permeable and irreversible caspase-3 inhibitor [1][2][3]. Apoptosis is a process of programmed cell death that occurs in multicellular organisms. |
Ac-DEVD-CHO |
|||
HY-P1001 | MedChemExpress | 5mg | EUR 456 |
Ac-DEVD-AMC |
|||
HY-P1003 | MedChemExpress | 5mg | EUR 308.4 |
Ac-DEVD-pNA |
|||
HY-P1006 | MedChemExpress | 25mg | EUR 538.8 |
Ac-DEVD-CHO |
|||
B1951-1 | Biovision | each | EUR 170.4 |
Ac-DEVD-CHO |
|||
B1951-5 | Biovision | each | EUR 496.8 |
Ac-DEVD-CMK |
|||
27315 | BPS Bioscience | 5 mg | EUR 340 |
Description: Caspase-3 Inhibitor |
Caspase-3 Substrate DEVD-AFC |
|||
1007-1000 | Biovision | each | EUR 770.4 |
Caspase-3 Substrate DEVD-AFC |
|||
1007-200 | Biovision | each | EUR 392.4 |
Ac-VEID-AFC |
|||
A8751-25 | ApexBio | 25 mg | EUR 547.2 |
Description: Ac-VEID-AFC is a fluorogenic substrate of caspase-6 (Km=30?M; Kcat/Km=168000 M-1sec-1) and related cysteine proteases. The sequence is based on the lamin A site of cleavage. |
Ac-VEID-AFC |
|||
A8751-5 | ApexBio | 5 mg | EUR 199.2 |
Description: Ac-VEID-AFC is a fluorogenic substrate of caspase-6 (Km=30?M; Kcat/Km=168000 M-1sec-1) and related cysteine proteases. The sequence is based on the lamin A site of cleavage. |
Ac-IETD-AFC |
|||
A8752-25 | ApexBio | 25 mg | EUR 547.2 |
Description: Ac-IETD-AFC is a fluorogenic substrate of caspase-8 and possesses amino aicd sequence IETD which is recognized by caspase-8-mediated proteolysis. It is also a substrate for caspase-3 processing enzyme, caspase-10, and granzyme B. |
Ac-IETD-AFC |
|||
A8752-5 | ApexBio | 5 mg | EUR 199.2 |
Description: Ac-IETD-AFC is a fluorogenic substrate of caspase-8 and possesses amino aicd sequence IETD which is recognized by caspase-8-mediated proteolysis. It is also a substrate for caspase-3 processing enzyme, caspase-10, and granzyme B. |
Ac-VDVAD-AFC |
|||
A8757-1 | ApexBio | 1 mg | EUR 174 |
Ac-VDVAD-AFC |
|||
A8757-10 | ApexBio | 10 mg | EUR 634.8 |
Ac-VDVAD-AFC |
|||
A8757-5 | ApexBio | 5 mg | EUR 375.6 |
Ac-LEVD-AFC |
|||
A8759-25 | ApexBio | 25 mg | EUR 547.2 |
Ac-LEVD-AFC |
|||
A8759-5 | ApexBio | 5 mg | EUR 199.2 |
Ac-WEHD-AFC |
|||
A8761-1 | ApexBio | 1 mg | EUR 174 |
Ac-WEHD-AFC |
|||
A8761-10 | ApexBio | 10 mg | EUR 579.6 |
Ac-WEHD-AFC |
|||
A8761-5 | ApexBio | 5 mg | EUR 348 |
Ac-YVAD-AFC |
|||
A8956-10 | ApexBio | 10 mg | EUR 351.6 |
Description: Ac-YVAD-AFC |
Ac-YVAD-AFC |
|||
A8956-5 | ApexBio | 5 mg | EUR 216 |
Description: Ac-YVAD-AFC |
Ac-IEPD-AFC |
|||
A4418-5 | ApexBio | 5 mg | EUR 388.8 |
Description: Peptide sequence shown to be preferred recognition motif for the serine protease granzyme B. Fluorogenic substrate. |
Ac-LEHD-AFC |
|||
A4419-10 | ApexBio | 10 mg | EUR 426 |
Description: Fluorogenic caspase substrate. Analog of the caspase-9 substrate, LEHD-AFC. |
Ac-LEHD-AFC |
|||
A4419-5 | ApexBio | 5 mg | EUR 259.2 |
Description: Fluorogenic caspase substrate. Analog of the caspase-9 substrate, LEHD-AFC. |
Ac-WEHD-AFC |
|||
B2214-25 | Biovision | each | EUR 810 |
Ac-WEHD-AFC |
|||
B2214-5 | Biovision | each | EUR 248.4 |
Ac-IEPD-AFC |
|||
B2526-25 | Biovision | each | EUR 1005.6 |
Ac-IEPD-AFC |
|||
B2526-5 | Biovision | each | EUR 301.2 |
Ac-Gly-Pro-AFC |
|||
I-2000.0005 | Bachem | 5.0mg | EUR 240 |
Description: Sum Formula: C19H18F3N3O5; CAS# [886993-02-8] |
Ac-Gly-Pro-AFC |
|||
I-2000.0025 | Bachem | 25.0mg | EUR 849.6 |
Description: Sum Formula: C19H18F3N3O5; CAS# [886993-02-8] |
Ac-Gly-Pro-AFC |
|||
I-2000.0100 | Bachem | 100.0mg | EUR 2473.2 |
Description: Sum Formula: C19H18F3N3O5; CAS# [886993-02-8] |
Ac-DEVD-CHO, Caspase-3 Inhibitor |
|||
10404 | Biotium | 5MG | EUR 368.4 |
Description: Minimum order quantity: 1 unit of 5MG |
Ac-DEVD-CHO, Caspase-3 Inhibitor |
|||
10404-1 | Biotium | 1MG | EUR 150 |
Description: Minimum order quantity: 1 unit of 1MG |
Ac-Tyr-Val-Ala-Asp-AFC |
|||
I-1705.0005 | Bachem | 5.0mg | EUR 385.2 |
Description: Sum Formula: C33H36F3N5O10; CAS# [219137-85-6] |
Ac-Tyr-Val-Ala-Asp-AFC |
|||
I-1705.0025 | Bachem | 25.0mg | EUR 1430.4 |
Description: Sum Formula: C33H36F3N5O10; CAS# [219137-85-6] |
Ac-Asp-Glu-Val-Asp-AFC |
|||
I-1725.0005 | Bachem | 5.0mg | EUR 385.2 |
Description: Sum Formula: C30H34F3N5O13; CAS# [201608-14-2] |
Ac-Asp-Glu-Val-Asp-AFC |
|||
I-1725.0025 | Bachem | 25.0mg | EUR 1430.4 |
Description: Sum Formula: C30H34F3N5O13; CAS# [201608-14-2] |
Ac-Leu-Glu-His-Asp-AFC |
|||
I-1820.0001 | Bachem | 1.0mg | EUR 139.2 |
Description: Sum Formula: C33H38F3N7O11; CAS# [210345-03-2] net |
Ac-Leu-Glu-His-Asp-AFC |
|||
I-1820.0005 | Bachem | 5.0mg | EUR 385.2 |
Description: Sum Formula: C33H38F3N7O11; CAS# [210345-03-2] net |
Ac-Leu-Glu-His-Asp-AFC |
|||
I-1820.0025 | Bachem | 25.0mg | EUR 1430.4 |
Description: Sum Formula: C33H38F3N7O11; CAS# [210345-03-2] net |
Ac-Leu-Glu-Val-Asp-AFC |
|||
I-1905.0005 | Bachem | 5.0mg | EUR 471.6 |
Description: Sum Formula: C32H40F3N5O11; CAS# [1092077-23-0] |
Ac-Leu-Glu-Val-Asp-AFC |
|||
I-1905.0025 | Bachem | 25.0mg | EUR 1778.4 |
Description: Sum Formula: C32H40F3N5O11; CAS# [1092077-23-0] |
Ac-Leu-Glu-Thr-Asp-AFC |
|||
I-1910.0001 | Bachem | 1.0mg | EUR 151.2 |
Description: Sum Formula: C31H38F3N5O12; CAS# [210345-02-1] |
Ac-Leu-Glu-Thr-Asp-AFC |
|||
I-1910.0005 | Bachem | 5.0mg | EUR 471.6 |
Description: Sum Formula: C31H38F3N5O12; CAS# [210345-02-1] |
Ac-Lys-Gln-Leu-Arg-AFC |
|||
I-2005.0001 | Bachem | 1.0mg | EUR 142.8 |
Description: Sum Formula: C35H51F3N10O8; CAS# [1802078-38-1] net |
Ac-Lys-Gln-Leu-Arg-AFC |
|||
I-2005.0005 | Bachem | 5.0mg | EUR 387.6 |
Description: Sum Formula: C35H51F3N10O8; CAS# [1802078-38-1] net |
Ac-Trp-Glu-His-Asp-AFC |
|||
I-2010.0001 | Bachem | 1.0mg | EUR 85.2 |
Description: Sum Formula: C38H37F3N8O11; CAS# [210344-99-3] net |
Ac-Trp-Glu-His-Asp-AFC |
|||
I-2010.0005 | Bachem | 5.0mg | EUR 212.4 |
Description: Sum Formula: C38H37F3N8O11; CAS# [210344-99-3] net |
Ac-DEVD-AMC *CAS 169332-61-0* |
|||
13402 | AAT Bioquest | 5 mg | EUR 158.4 |
Ac-DEVD-CHO *CAS 169332-60-9* |
|||
13403 | AAT Bioquest | 1 mg | EUR 158.4 |
Ac-DEVD-pNA *CAS 189950-66-1* |
|||
13405 | AAT Bioquest | 5 mg | EUR 158.4 |
Ac-IETD-AFC *CAS 211990-57-7* |
|||
13410 | AAT Bioquest | 5 mg | EUR 262.8 |
Caspase 3 Substrate 1m (Apopain), fluorogenic; Ac-DEVD-AMC |
|||
5-00935 | CHI Scientific | 4 x 5mg | Ask for price |
Caspase 3 Substrate 1m (Apopain), fluorogenic; Ac-DEVD-AMC Peptide |
|||
20-abx265595 | Abbexa |
|
|
Z-DEVD-pNA |
|||
A8748-25 | ApexBio | 25 mg | EUR 338.4 |
Description: Z-DEVD-pNA is a colorimetric substrate for caspase-3 with increased cell permeability. Sequence is based on PARP poly(ADP-ribose) polymerase which is clevaved by caspase-3 at the amino acid sequence DEVD[1]. |
Z-DEVD-pNA |
|||
A8748-5 | ApexBio | 5 mg | EUR 142.8 |
Description: Z-DEVD-pNA is a colorimetric substrate for caspase-3 with increased cell permeability. Sequence is based on PARP poly(ADP-ribose) polymerase which is clevaved by caspase-3 at the amino acid sequence DEVD[1]. |
Z-DEVD-AMC |
|||
13421 | AAT Bioquest | 5 mg | EUR 211.2 |
Z-DEVD-pNA |
|||
13422 | AAT Bioquest | 5 mg | EUR 158.4 |
Z-DEVD-FMK |
|||
A1920-1 | ApexBio | 1 mg | EUR 135.6 |
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
Z-DEVD-FMK |
|||
A1920-10 | ApexBio | 10 mg | EUR 408 |
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
Z-DEVD-FMK |
|||
A1920-25 | ApexBio | 25 mg | EUR 616.8 |
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
Z-DEVD-FMK |
|||
A1920-5 | ApexBio | 5 mg | EUR 268.8 |
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
Z-DEVD-FMK |
|||
A1920-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 351.6 |
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
Z-DEVD-FMK |
|||
A1920-S | ApexBio | Evaluation Sample | EUR 97.2 |
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
Z-DEVD-FMK |
|||
HY-12466 | MedChemExpress | 10mg | EUR 471.6 |
Z-DEVD-FMK |
|||
13303 | AAT Bioquest | 1 mg | EUR 102 |
TF3-DEVD-FMK |
|||
13474 | AAT Bioquest | 25 Tests | EUR 109 |
FITC-DEVD-FMK |
|||
9499-100 | Biovision | each | EUR 430.8 |
Biotin-DEVD-FMK |
|||
1124-20C | Biovision | each | EUR 444 |
Z-DEVD-FMK |
|||
1143-1 | Biovision | each | EUR 379.2 |
Z-DEVD-FMK |
|||
1143-5 | Biovision | each | EUR 966 |
Z-DEVD-FMK |
|||
27314 | BPS Bioscience | 5 mg | EUR 215 |
Description: Caspase-3 Inhibitor |
H-Ala-AFC |
|||
I-1455.0250 | Bachem | 250.0mg | EUR 704.4 |
Description: Sum Formula: C13H11F3N2O3; CAS# [126910-31-4] net |
H-Ala-AFC |
|||
I-1455.1000 | Bachem | 1.0g | EUR 2037.6 |
Description: Sum Formula: C13H11F3N2O3; CAS# [126910-31-4] net |
FITC-C6-DEVD-FMK |
|||
13406 | AAT Bioquest | 1 mg | EUR 576 |
FITC-C6-DEVD-FMK |
|||
13408 | AAT Bioquest | 100 ug | EUR 262.8 |
(Z-DEVD)2-R110 |
|||
13430 | AAT Bioquest | 1 mg | EUR 158.4 |
EZSolution? Q-DEVD-OPh |
|||
1178-1 | Biovision | each | EUR 326.4 |
AC-PEG-AC |
|||
abx085037-10kDa1g | Abbexa | 10 kDa; 1 g | EUR 393.6 |
AC-PEG-AC |
|||
abx085037-1kDa1g | Abbexa | 1 kDa; 1 g | EUR 393.6 |
AC-PEG-AC |
|||
abx085037-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 393.6 |
H-Ala-Pro-AFC |
|||
I-1680.0050 | Bachem | 50.0mg | EUR 675.6 |
Description: Sum Formula: C18H18F3N3O4; CAS# [125791-92-6] |
H-Ala-Pro-AFC |
|||
I-1680.0250 | Bachem | 250.0mg | EUR 2590.8 |
Description: Sum Formula: C18H18F3N3O4; CAS# [125791-92-6] |
Z-DEVD-ProRed™ 620 |
|||
13433 | AAT Bioquest | 1 mg | EUR 367.2 |
Caspase-3 Substrate DEVD-pNA |
|||
1008-1000 | Biovision | each | EUR 770.4 |
Caspase-3 Substrate DEVD-pNA |
|||
1008-200 | Biovision | each | EUR 392.4 |
Ac-Lys(Ac)-OH |
|||
E-1775.0001 | Bachem | 1.0g | EUR 151.2 |
Description: Sum Formula: C10H18N2O4; CAS# [499-86-5] |
Ac-Lys(Ac)-OH |
|||
E-1775.0005 | Bachem | 5.0g | EUR 501.6 |
Description: Sum Formula: C10H18N2O4; CAS# [499-86-5] |
Ac-GPK(Ac)-pNA |
|||
5-00556 | CHI Scientific | 4 x 5mg | Ask for price |
Ac-Tyr(Ac)-OH |
|||
5-03625 | CHI Scientific | 25g | Ask for price |
Ac-Tyr(Ac)-OH |
|||
5-03626 | CHI Scientific | 100g | Ask for price |
AC-PEG-AC,10K |
|||
33-HO009009-10K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
AC-PEG-AC,1K |
|||
33-HO009009-1K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
AC-PEG-AC,20K |
|||
33-HO009009-20K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
AC-PEG-AC,2K |
|||
33-HO009009-2K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
AC-PEG-AC,3.4K |
|||
33-HO009009-3.4K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
AC-PEG-AC,5K |
|||
33-HO009009-5K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
H-Gly-Ala-Pro-AFC |
|||
I-1700.0025 | Bachem | 25.0mg | EUR 849.6 |
Description: Sum Formula: C20H21F3N4O5; CAS# [219137-81-2] |
H-Gly-Ala-Pro-AFC |
|||
I-1700.0100 | Bachem | 100.0mg | EUR 2473.2 |
Description: Sum Formula: C20H21F3N4O5; CAS# [219137-81-2] |
Caspase-8 Substrate IETD-AFC |
|||
1062-1000 | Biovision | each | EUR 770.4 |
Caspase-8 Substrate IETD-AFC |
|||
1062-200 | Biovision | each | EUR 392.4 |
Caspase-6 Substrate VEID-AFC |
|||
1069-1000 | Biovision | each | EUR 770.4 |
Caspase-6 Substrate VEID-AFC |
|||
1069-200 | Biovision | each | EUR 392.4 |
Caspase-2 Substrate VDVAD-AFC |
|||
1071-1000 | Biovision | each | EUR 770.4 |
Caspase-2 Substrate VDVAD-AFC |
|||
1071-200 | Biovision | each | EUR 392.4 |
Caspase-9 Substrate LEHD-AFC |
|||
1075-1000 | Biovision | each | EUR 770.4 |
Caspase-9 Substrate LEHD-AFC |
|||
1075-200 | Biovision | each | EUR 392.4 |